Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
Cardiometabolic Health Congress (CMHC 2026) 14 - 17 October 2026
Time to insulin initiation after escalating to semaglutide 2.0 mg versus switching to tirzepatide among adults with type 2 diabetes receiving semaglutide 1.0 mg
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.